Longfellow Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Longfellow Investment Management's BMY Position: Q1 2026 in Review
Longfellow Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 33% in Q1 2026, selling an estimated $2.84M and leaving 100,282 shares worth $6.08M. The position accounts for 1.27% of the portfolio, ranked #16.
Longfellow Investment Management first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $8.4M in Q4 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Longfellow Investment Management held 100,282 shares of Bristol-Myers Squibb worth $6.08M as of Q1 2026.
- Longfellow Investment Management sold 48,701 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.84M.
- Bristol-Myers Squibb made up 1.27% of Longfellow Investment Management's portfolio in Q1 2026, its #16 holding.
- Longfellow Investment Management first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
- Longfellow Investment Management's Bristol-Myers Squibb position peaked at $8.4M in Q4 2024.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Longfellow Investment Management's 13F filing for Q1 2026, filed 12 May 2026.